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Background
Success of combination ART therapy in treating HIV
infection is hampered due to emergence of drug resis-
tant mutations in polymerase gene. The present study
was conducted to find out the prevalence of drug resis-
tance-conferring mutations in protease gene in HIV-1
infected patients.
Methodology
CD4 cells estimation was done in all patients. The pro-
tease gene was amplified from pro-viral DNA by nested
PCR and then sequenced. Mutational analysis and sub-
typing were done by using Stanford database and REGA
HIV-1 subtyping tool, respectively.
Results
Among 35 patients, there were 17 drug naïve and 18 first
line drugs experienced HIV-1 infected patients (22 males
& 13 females; mean age: 35.95 years; mean CD4 cells:
216.4cells/mm
3). Majority of our patients showed muta-
tions at T12S/T (82.85%), K14R (40%), I15V (71.42%),
L19I/T/V/M (97.14%), M36I (71.42%), R41K (88.57%),
L63P (65.71%), H63K (100%) and L89M (74.28%) posi-
tions in both group of patients while other mutations
were at positions 35, 37, 45, 60, 62, 77, and 82 in few
cases. Interestingly, one first line drug experienced
patient showed major DR mutations at D30N and M46I
positions. Majority (94.28%) was belonging to subtype C
and 2 patients were belonging to subtypes A (A1).
Conclusion
HIV-1 subtype C predominates in northern India fol-
lowed by subtype A. Major DR mutation M46I are
suggested to confer low levels of resistance to ATV,
FPV, IDV, LPV, NFV and TPV.D30N confers resistance
only to NFV. Resistance testing in HIV-1 infected
patients should be performed before the initiation of
therapy for better therapeutic outcome.
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